Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

ORMP Price Correlated With Financials For Oramed Pharmaceuticals

See how revenue, income, cash flow, and balance sheet financials have changed over 25 quarters since 2015. Compare with ORMP stock chart to see long term trends.

ORMP Stock Compared to Quarterly

ORMP Income Statement

Revenue, Net:674000
Selling, General & Admin Expense:585000
Research & Development Expense:6410000
Total Operating Expenses:67000
Operating Income:-8060000
Net Income:-8098000
Earnings Per Share, Basic:0.22
Shares Outstanding, Basic Avg:38283841
Revenue Per Share:0.0176

ORMP Cash Flow

Operating Activities Net Income:
Net Cash from Operations:-6903000
Net Cash from Operations Per Share:-0.1803
Net Cash from Financing Activities:60563000
Property, Plant & Equipment Purchases:null
Net Cash from Investing Activities:-99048000
Net Change in Cash & Equivalents:-45365000

ORMP Balance Sheet

Cash and Cash Equivalents:31880000
Short-Term Investments:7573000
Total Current Assets:152332000
Property, Plant & Equipment, Net:385000
Total Assets:182450000
Total Short-Term Liabilities:7660000

Data imported from Oramed Pharmaceuticals Inc. SEC filings. Check original filings before making any investment decision.